𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of a standardised 500 unit dose of Dysport®(Clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study

✍ Scribed by Wissel, J.; Kanovsky, P.; Ruzicka, E.; Bares, M.; Hortova, H.; Streitova, H.; Jech, R.; Roth, J.; Brenneis, C.; Müller, J.

Book ID
113040519
Publisher
Springer
Year
2001
Tongue
English
Weight
432 KB
Volume
248
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of botulinum type A
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double-blind, placebo-controlled study
✍ Daniel Truong; Drake D. Duane; Joseph Jankovic; Carlos Singer; Lauren C. Seeberg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Abstract Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia. This multicenter, double‐blind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States. Ei

Authors’ reply to the letter to the edit
Authors’ reply to the letter to the editor by Peter Reilich and Benedikt G.H. Schoser regarding the published article entitled “Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport®) for the relief of upper back myofascial pain syndrome: Results from a randomised double-blind placebo-controlled multicentre study”, Pain 2006;125:82–8.
✍ Hartmut Göbel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB